Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Contribution of neoadjuvant chemotherapy and radiation therapy (intensity-modulated radiation therapy with concurrent chemotherapy versus stereotactic body radiation therapy alone) on tumor volume regression in patients with borderline resectable or locally advanced pancreatic ductal adenocarcinoma: A single institution experience.
Authors
Jacob K. Jamison
Weill Cornell Medical College, New York, NY
Jacob K. Jamison , Hope Cho , Michael S. May , Lyndon Luk , Milana Flusberg , Mariya Kobi , Volkan Beylergil , Ksenia Skorohodova , Alexander G Raufi , David Paul Horowitz , Michael D. Kluger , Samuel M Pan , Lisa A. Kachnic , Beth Schrope , Susan Elaine Bates , Ruth Aroon White , Ryan H. Moy , Linda Wu , John A. Chabot , Gulam Abbas Manji
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Other
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 707)
DOI
10.1200/JCO.2024.42.3_suppl.707
Abstract #
707
Poster Bd #
N16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Nivolumab and a CCR2/CCR5 dual antagonist (BMS-813160) with or without GVAX for locally advanced pancreatic ductal adenocarcinomas: Results of phase I study.
First Author: Eric Christenson
Poster
2016 Gastrointestinal Cancers Symposium
Non-invasive monitoring of patient-derived orthotopic xenograft: An optimal system for rapid in vivo testing.
First Author: Mayrim V. Rios Perez
Poster
2014 Gastrointestinal Cancers Symposium
Effect of intensity-modulated radiation therapy with SIB technique on local control and toxicity for neoadjuvant pelvic radiation with concurrent 5-fluorouracil based chemotherapy for rectal cancer compared with three-dimensional conformal radiation therapies.
First Author: Nitika Thawani
Poster
2024 ASCO Breakthrough
Utility of radiomic features in predicting clinical outcomes in stage II-III pancreatic cancer.
First Author: Haruka Itakura